About GIANT BioSystems
Revolutionizing antimicrobial and small-molecule screening with high-precision microfluidics.
Our Mission
GIANT BioSystems is building the fastest antimicrobial susceptibility testing (AST) platform in the world — delivering actionable results in 2 hours to support earlier targeted therapy decisions.
In severe infections like sepsis, delays in effective treatment can be deadly. GIANT is designed to help clinicians move from empiric therapy to targeted therapy faster — improving outcomes and reducing healthcare burden.